ES2156584T3 - Androgenos para estimular el sistema nervioso central. - Google Patents

Androgenos para estimular el sistema nervioso central.

Info

Publication number
ES2156584T3
ES2156584T3 ES93912552T ES93912552T ES2156584T3 ES 2156584 T3 ES2156584 T3 ES 2156584T3 ES 93912552 T ES93912552 T ES 93912552T ES 93912552 T ES93912552 T ES 93912552T ES 2156584 T3 ES2156584 T3 ES 2156584T3
Authority
ES
Spain
Prior art keywords
nervous system
central nervous
androgens
stimulate
turinabol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93912552T
Other languages
English (en)
Inventor
Claudia Mattern
Rudiger Hacker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CUM Pharma Consulting Anstalt
Original Assignee
CUM Pharma Consulting Anstalt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CUM Pharma Consulting Anstalt filed Critical CUM Pharma Consulting Anstalt
Application granted granted Critical
Publication of ES2156584T3 publication Critical patent/ES2156584T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

UTILIZACION DE UN MEDICAMENTO QUE CONTIENE MESTANOLONA Y/O TURINABOL ORAL PARA EL INCREMENTO Y OPTIMIZACION DEL GRADO DE ACTIVACION DEL SISTEMA NERVIOSO CENTRAL Y/O PARA LA PROFILAXIS Y LA TERAPIA DE OSTEOPOROSIS.
ES93912552T 1992-06-03 1993-05-28 Androgenos para estimular el sistema nervioso central. Expired - Lifetime ES2156584T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4218292A DE4218292C1 (de) 1992-06-03 1992-06-03 Verwendung eines Arzneimittels mit einem Gehalt an Mestanolon und/oder 4-Chlor-1-dehydromethyltestosteron

Publications (1)

Publication Number Publication Date
ES2156584T3 true ES2156584T3 (es) 2001-07-01

Family

ID=6460300

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93912552T Expired - Lifetime ES2156584T3 (es) 1992-06-03 1993-05-28 Androgenos para estimular el sistema nervioso central.

Country Status (7)

Country Link
US (1) US5591732A (es)
EP (1) EP0597071B1 (es)
JP (1) JP2882544B2 (es)
CA (1) CA2113425C (es)
DE (2) DE4218292C1 (es)
ES (1) ES2156584T3 (es)
WO (1) WO1993024128A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998023274A1 (en) * 1996-11-25 1998-06-04 Merck & Co., Inc. Androgenic and bisphosphonic agents coadministered to treat diseases
US6376477B2 (en) 1996-11-25 2002-04-23 Merck & Co., Inc. Combination of an agent that binds to the androgen receptor and a bisphosphonic acid in the prevention and/or treatment of diseases involving calcium or phosphate metabolism

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2345376A1 (de) * 1973-09-06 1975-03-20 Schering Ag Pharmazeutische zubereitung ii
US4898857A (en) * 1984-10-29 1990-02-06 Chaovanee Aroonsakul Treating control nervous system diseases
US4902680A (en) * 1984-10-29 1990-02-20 Chaovanee Aroonsakul Treating central nervous system diseases
JPS61126069A (ja) * 1984-11-21 1986-06-13 Res Dev Corp Of Japan プロスタグランジン誘導体
US5208227A (en) * 1987-08-25 1993-05-04 University Of Southern California Method, compositions, and compounds for modulating brain excitability
US5120723A (en) * 1987-08-25 1992-06-09 University Of Southern California Method, compositions, and compounds for modulating brain excitability
US5183815A (en) * 1991-01-22 1993-02-02 Merck & Co., Inc. Bone acting agents

Also Published As

Publication number Publication date
EP0597071A1 (de) 1994-05-18
JP2882544B2 (ja) 1999-04-12
WO1993024128A1 (de) 1993-12-09
US5591732A (en) 1997-01-07
JPH07503736A (ja) 1995-04-20
EP0597071B1 (de) 2001-04-18
CA2113425A1 (en) 1993-12-09
CA2113425C (en) 1998-08-11
DE4218292C1 (de) 1994-02-03
DE59310163D1 (de) 2001-05-23

Similar Documents

Publication Publication Date Title
ES2156150T3 (es) Combinacion terapeutica que contiene interferon.
ES2153394T3 (es) Medicamento que contiene la subunidad p40 de interleuquina-12.
ES2132105T3 (es) 2-aminometil-cromanos como principios activos en farmacos para el tratamiento de enfermedades del sistema nervioso central.
ES2139132T3 (es) Composiciones farmaceuticas activas en la terapia de desordenes del sueño.
ES2123064T3 (es) Uso de melatonina en pequeñas dosis orales como somnifero.
ES2178048T3 (es) Uso de rifaximina como medicamento para el tratamiento de diarrea por criptosporidiosis.
EP0209689A3 (en) Use of tetrahydrobiopterins in the treatment of infantile autism
MX9301929A (es) Derivados de pirimidina y procedimientos para su preparacion.
ES2167592T3 (es) Preparaciones medicamentosas que contienen un enantiomero de bromuro de ipratropio con duracion de la accion prolongada.
ES2071484T3 (es) Derivados de 2,4-diaminoquinazolinas para aumentar la actividad antitumoral.
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
ATE82121T1 (de) Arzneimittel fuer die therapeutische behandlung von alopezie.
ES2160712T3 (es) Nueva preparacion farmaceutica para tratamiento del dolor.
ES2188586T3 (es) Utilizacion de inhibidores del complemento para la preparacion de un medicamento para la profilaxis y terapia de enfermedades inflamatorias intestinales y de la piel, asi como purpura.
ES2040106T3 (es) Utilizacion de la acetil d-carnitina en el tratamiento terapeutico del glaucoma.
MX9701385A (es) Preparacion de producto combinado para usarse en enfermedades inmunologicas.
ES2101317T3 (es) Medicamento para aumentar el nivel de testosterona.
ES8700232A1 (es) Un procedimiento para producir 1a,25-dihidroxi-26,27-dime- tilcolecalciferol
ES2173911T3 (es) Uso de glicosidos en vitamina d para el tratamiento o prevencion de la osteoporosis.
ES2068714T3 (es) Derivados de pirimidina para aumentar la actividad antitumoral.
ES2135412T3 (es) Uso de antagonistas o agonistas parciales del receptor 5-ht 1a para el tratamiento y la prevencion de trastornos cognitivos.
ES2094834T3 (es) Dispositivo para el lavado, para finalidades terapeuticas o de higiene, de conductos internos humanos o animales.
YU42298A (sh) Upotreba olanzapina za pripremanje leka korisnog kod akutnog bola
ES2159357T3 (es) Derivados terpenoides (sarcodictinas) utiles como agentes antitumorales.
ES2125356T3 (es) Empleo de leflunomida para la inhibicion de interleuquina 8.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 597071

Country of ref document: ES